Philadelphia, Pennsylvania–(Newsfile Corp. – January 10, 2025) – Nationally acknowledged regulation agency Berger Montague PC informs buyers {that a} lawsuit was filed in opposition to PACS Group, Inc. (“PACS” or the “Company”) (NYSE: PACS) on behalf of purchasers of PACS securities between April 8, 2024 and November 21, 2024, inclusive (the “Class Period”).
Buyers that suffered losses from PACS (NYSE: PACS) investments can observe the hyperlink under for extra info relating to the lawsuit:
CLICK HERE to study extra concerning the lawsuit.
Buyers who bought or acquired PACS securities throughout the Class Interval might, no later than JANUARY 13, 2025, search to be appointed as a lead plaintiff consultant of the category.
Headquartered in Farmington, Utah, PACS operates expert nursing amenities and post-acute care amenities within the U.S.
On November 4, 2024, Hindenburg Analysis printed a report alleging that, amongst different issues, PACS misused COVID waivers to inflate Medicare reimbursements, in addition to partaking in different income practices which misrepresented the Firm’s monetary well being. On this information, PACS’ share worth dropped $11.93 per share – 27.8 % – to shut at $31.01 per share on November 4, 2024.
Then, on November 6, 2024, the Firm introduced that it could delay the discharge of its third-quarter 2024 monetary outcomes because of an investigation by the Firm’s Audit Committee into current allegations regarding its reimbursement and referral practices. PACS additionally disclosed that it had obtained civil investigative calls for from the federal authorities relating to these practices. On this information, PACS’ share worth dropped $11.45 per share – 38.8 % – to shut at $18.09 per share on November 6, 2024.
For extra info or to discover ways to take part on this litigation, please contact Berger Montague: Andrew Abramowitz at aabramowitz@bm.internet or (215) 875-3015, or Peter Hamner at phamner@bm.internet, or CLICK HERE.
A lead plaintiff is a consultant celebration who acts on behalf of all class members in directing the litigation. The lead plaintiff is normally the investor or small group of buyers who’ve the most important monetary curiosity and who’re additionally satisfactory and typical of the proposed class of buyers. The lead plaintiff selects counsel to signify the lead plaintiff and the category and these attorneys, if accepted by the court docket, are lead or class counsel. Your capacity to share in any restoration shouldn’t be, nevertheless, affected by the choice whether or not or to not function a lead plaintiff. Speaking with any counsel shouldn’t be essential to take part or share in any restoration achieved on this case. Any member of the purported class might transfer the Courtroom to function a lead plaintiff via counsel of his/her selection, or might select to do nothing and stay an inactive class member.
Berger Montague, with places of work in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco and Chicago, has been a pioneer in securities class motion litigation since its founding in 1970. Berger Montague has represented particular person and institutional buyers for over 5 a long time and serves as lead counsel in courts all through america.
To view the supply model of this press launch, please go to https://www.newsfilecorp.com/launch/236814
